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Abstract 
 
The group C SOX transcription factors SOX4, -11 and -12 play important and mutually 
overlapping roles in development of a number of organs. Here, we examined the role of SoxC 
genes during gonadal development in mice. All three genes were expressed in developing 
gonads of both sexes, predominantly in somatic cells, with Sox4 being most strongly 
expressed. Sox4 deficiency resulted in elongation of both ovaries and testes, and an increased 
number of testis cords. While female germ cells entered meiosis normally, male germ cells 
showed reduced levels of differentiation markers Nanos2 and Dnmt3l and increased levels of 
pluripotency genes Cripto and Nanog, suggesting that SOX4 may normally act to restrict the 
pluripotency period of male germ cells and ensure their proper differentiation. Finally, our 
data reveal that SOX4 (and, to a lesser extent, SOX11 and -12) repressed transcription of the 
sex-determining gene Sox9 via an upstream testis-specific enhancer core (TESCO) element in 
fetal gonads, raising the possibility that SOXC proteins may function as transcriptional 
repressors in a context-dependent manner.  
 
Introduction 
 
In mice, gonadal development starts around 10.5 days post coitum (dpc) when the coelomic 
epithelium overlying the ventromedial surface of the mesonephros thickens to form a pair of 
sexually bipotent genital ridges. In XY genital ridges, the subsequent expression of the Y-
linked male sex-determining gene Sry (Gubbay et al., 1990; Koopman et al., 1991; Sinclair et 
al., 1990) in somatic precursor cells marks the onset of testis differentiation. SRY activates its 
key target Sox9 by binding to an upstream testis-specific enhancer core (TESCO) element 
(Sekido and Lovell-Badge, 2008). SOX9 directs somatic precursor cells to differentiate into 
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Sertoli cells, which in turn orchestrate the development of other testicular cell lineages, 
including fetal Leydig cells (Svingen and Koopman, 2013). In the absence of Sry, XX 
somatic precursor cells differentiate towards granulosa cells under the influence of 
unopposed RSPO1/WNT4/ß-Catenin and FOXL2 signalling (Nicol and Yao, 2014). As a 
result, XX genital ridges form ovaries. 
 
Accompanying the differentiation of testicular cell lineages, mouse fetal testes undergo 
morphological changes from 11.5 dpc, including rapid growth, testis cord formation and 
vascularisation (Svingen and Koopman, 2013; Ungewitter and Yao, 2013). Along with the 
rapid growth, the shape of fetal testes changes significantly. Width of the testes increases ~4-
fold (Nel-Themaat et al., 2009) by 13.5 dpc due to a combination of somatic cell proliferation 
(Schmahl et al., 2000) and cell migration from the mesonephroi and coelomic epithelium  
(Karl and Capel, 1998; Martineau et al., 1997). At the same time, fetal testes become shorter 
(Nel-Themaat et al., 2009), presumably due to cells migrating more towards the centre of the 
gonad (Nel-Themaat et al., 2010). In contrast, fetal ovaries show no dramatic morphological 
changes within this time window apart from a slight increase in width and a reduction in 
length.  
 
Depending on the sexual fate choice of gonadal somatic cells, fetal germ cells adopt male or 
female fate. In fetal ovaries, germ cells enter meiosis in response to retinoic acid, and express 
meiotic markers including Stra8 and Sycp3 (Bowles et al., 2006; Koubova et al., 2006). In 
contrast, germ cells in fetal testes avoid entering meiosis and are instead mitotically arrested 
(McLaren, 1984). They transiently activate the Nodal/Cripto signalling pathway (Spiller et 
al., 2012), down-regulate pluripotency genes such as Nanog, Sox2 and Oct3/4 (Pou5f1) 
(Western et al., 2010), and begin to express genes marking the commitment to 
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spermatogenesis, including Nanos2 (Suzuki and Saga, 2008) and Dnmt3l (Bourc'his and 
Bestor, 2004).  
 
SRY and SOX9 belong to the multi-member SOX family of transcription factors defined by 
the presence of an SRY-type HMG (high-mobility group) box (SOX) DNA-binding domain. 
Based on the sequence homology of the HMG box, the 20 mammalian SOX proteins can be 
classified into groups A-H (Bowles et al., 2000). The SOXC group comprises three members, 
SOX4, SOX11 and SOX12. All possess a transactivation domain at the carboxyl-terminus, 
with SOX11 being the strongest transactivator (Dy et al., 2008). SoxC genes are expressed 
widely in the early mouse embryo and have been shown to redundantly function in a dose-
dependent manner in the development of multiple organs (Bhattaram et al., 2010). Sox4
 –/–
 
mice die at 14.5 dpc due to a heart outflow tract malformation (Schilham et al., 1996). Sox11
 
–/–
 mice develop multiple organ defects and die at birth with similar heart malformations but 
of less severity compared with Sox4
 –/–
 mice (Sock et al., 2004). Sox12
 –/–
 mice are grossly 
normal (Hoser et al., 2008).  
 
Northern blotting has previously revealed strong Sox4 expression in adult mouse thymus, 
ovaries and testes (van de Wetering et al., 1993), prompting us to investigate whether this 
gene might also play a role in fetal gonad development. In the present study, we show that 
Sox4 is highly expressed in both sexes in gonadal supporting cells, the organising centre of 
gonad organogenesis. By analysing Sox4
 –/–
 embryos, we found that Sox4 loss of function 
resulted in a dysregulation of the organ shape of both ovaries and testes. Although the 
specification of gonadal somatic cell lineages and female germ cells appeared unperturbed in 
Sox4
 –/–
 fetal gonads, the spermatogenic differentiation of male germ cells was significantly 
compromised. In addition, our results suggest that SOX4 (and possibly SOX11/12) may 
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function as a transcriptional repressor in fetal testes, contributing to the precise regulation of 
Sry and Sox9. Taken together, our data indicate that SOX4 plays important roles in mouse 
gonad development by modulating gonad morphogenesis and promoting male germ cell 
differentiation in vivo.  
 
 
  
  6 
Materials and methods 
Mice 
All animal procedures were approved by the Animal Care Committee at the Atlantic 
Veterinary College, University of Prince Edward Island or the University of Queensland 
Animal Ethics Committee. Sox4
 +/–
 strain (Schilham et al., 1996), Wt1-RG red-green reporter 
strain (Zhao et al., 2014b), and W
 e
 strain (Buehr et al., 1993) have been described previously. 
Embryos were collected from timed matings of various strains, with noon of the day on 
which the copulatory plug was observed designated 0.5 dpc. 
 
In situ hybridisation  
Section in situ hybridisation was performed following a previously described protocol 
(Wilhelm et al., 2007) with modifications: 7-μm paraformaldehyde-fixed paraffin sections 
were dewaxed, rehydrated, proteinase K-treated, refixed, acetylated and pre-hybridised as 
described (Wilhelm et al., 2007). Digoxigenin (DIG)-labelled riboprobes were heat denatured 
at 85 C for 5 min and cooled on ice before adding to the hybridisation buffer to a final 
concentration of 1 μg/ml. Hybridisation was carried out at 65 C overnight. Slides were 
subsequently washed in 5 SSC for 25 min at 65 C and NTE buffer (10 mM Tris-HCl, pH 
7.5, 0.5 M NaCl, and 1 mM EDTA, pH 8) for 15 min at room temperature before RNase A (5 
μg/ml) treatment in NTE buffer at 37 C for 2 15 min. Slides were washed sequentially in 
2 SSC at 65 C for 10 min, 0.5 SSC at 65 C for 30 min and room temperature for 15 min, 
MAB buffer (0.1 M Maleic acid, 0.15 M NaCl, pH 7.5) for 10 min, and MABT buffer (MAB 
buffer containing 0.1% Tween-20) for 10 min, before incubating for 45 min in MABT buffer 
containing 2% Blocking reagent (Roche) and 5% heat-inactivated horse serum. Anti-DIG-AP 
antibody (Roche) at 1:1000 dilution in MABT buffer was added to the slides and incubated at 
room temperature for 1 h. Slides were subsequently washed two times in MABT buffer and 
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three times in NTT buffer (0.1 M Tris-HCl, pH 9.5, 0.1 M NaCl, and 0.1% Tween-20) before 
incubating with BM purple solution (Roche) until optimal staining was achieved. The probe 
sequences of Sox4, Sox11, and Sox12 have been described previously (Huang et al., 2013). 
 
Whole-mount in situ hybridisation with a DIG-labelled riboprobe for the myoD gene (Ashe et 
al., 2012) was performed essentially as described (Hargrave et al., 2006).  
 
Cell sorting 
Fetal testes and ovaries (with mesonephros tissue removed) were dissected from Wt1-RG 
embryos at 13.5 dpc and pooled (n = 4). Gonad tissue was incubated with 0.05% trypsin for 5 
min at 37 C followed by mechanical dissociation with 18G and 23G needles sequentially. 
Cells were sorted for mCherry and EGFP fluorescence on an Influx Flow Sorter (BD 
Biosciences). Two cell populations were isolated from ovarian tissue, namely RG
 +
 (mCherry
 
+ 
EGFP
 +
) somatic cells and mCherry
 – 
EGFP
 –
 (RG
 –
) germ cells (Supplementary Fig. S1). 
Three distinct populations were isolated from fetal testes: RG
 Hi
 Sertoli cells, RG
 Lo
 interstitial 
cells (including fetal Leydig cells), and RG
 –
 germ cells (Supplementary Fig. S1).  
 
Histology 
Embryos were fixed overnight in 4% paraformaldehyde and embedded in paraffin. Briefly, 7-
μm paraffin sections were de-waxed in xylene, rehydrated through an ethanol series, then 
stained sequentially in haematoxylin and eosin solution. Images were captured on a BX-51 
microscope (Olympus). 
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Immunofluorescence 
Immunofluorescence staining was performed on 7-μm paraformaldehyde-fixed paraffin 
sections as described (Zhao et al., 2015). Images were captured on a LSM710 confocal 
microscope (Zeiss). Primary antibodies were used at the following dilutions: goat-anti-AMH 
(Santa Cruz C-20), 1:500; rabbit anti-HSD3 (Transgenic Inc. KAL-KO607), 1:500; rabbit 
anti-FOXL2 (Polanco et al., 2010), 1:500; rabbit anti-Laminin (Sigma L9393), 1:300; rabbit 
anti-DDX4 (Abcam ab13840), 1:800; mouse anti-SCP3 (Abcam ab97672), 1:200; mouse 
anti-DDX4 (Abcam ab27591), 1:500; rabbit anti-ARL13B (Proteintech 17711-1-AP), 1:300; 
rabbit anti-SRY (Wilhelm et al., 2005), 1:100; mouse anti-SOX9 (Abnova H00006662-M01), 
1:200; rabbit anti-cleaved Caspase-3 (Cell Signaling #9664), 1:600; rabbit anti-Ki67 (Abcam 
ab15580), 1:100. 
 
Quantitative RT-PCR (qRT-PCR)  
mRNA expression analysis was performed as described (Bagheri-Fam et al., 2015). Embryos 
at 13.5 dpc were collected and stored in RNAlater solution (Qiagen). Fetal gonads were then 
dissected in RNAlater solution with mesonephros removed. Total RNA was extracted using 
RNeasy Micro kit (Qiagen) and cDNA synthesized using a high-capacity cDNA kit (Life 
Tech). Quantitative PCR was conducted with SYBR Green mix (Life Tech) on a ViiA7 
machine (Life Tech). Primer sequences have been described previously (Huang et al., 2013; 
Zhao et al., 2015). Relative expression was calculated using ΔCt method with Tbp as the 
normalizing control (Svingen et al., 2009). Multiplicity-adjusted P values were calculated 
using GraphPad Prism 7. 
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Luciferase reporter assays 
Luciferase reporter assays were conducted as described (Zhao et al., 2014a). Briefly, 
HEK293 cells were co-transfected with the TESCO-Luc construct (Sekido and Lovell-Badge, 
2008), an empty pcDNA3 or a pcDNA3-Sf1 construct, an empty vector or an expression 
construct containing Sry or Sox9 coding sequence, in combination with an expression 
construct containing coding sequence of Sox4, 11 or 12 (Huang et al., 2013). A CMV-renilla 
luciferase plasmid was included as a control for transfection efficiency. Cell lysates were 
harvested 48 h post-transfection and luciferase activities measured using a Dual Luciferase 
kit (Promega) on a POLARstar Omega luminometer (BMG Labtech). Statistical significance 
was determined with one-way ANOVA with Tukey’s range test for multiple comparisons 
performed using GraphPad Prism 7. 
 
Image quantification 
For morphometric analysis of fetal urogenital organs, fetal gonads and kidneys were 
dissected from 13.5 dpc embryos and imaged with a Leica EC3 digital camera attached to a 
Leica MZ7.5 stereomicroscope. Length and width of each organ were measured using ImageJ 
software. Embryo trunk length was measured using ImageJ on embryos previously stained by 
whole-mount in situ hybridisation with a myoD riboprobe as described (Wainwright et al., 
2014). Number of external testis cords (those running immediately beneath the coelomic 
epithelium) were counted on the central sagittal section of the fetal testis (the largest plane). 
Multiplicity-adjusted P values were calculated using GraphPad Prism 7. 
 
For quantifying apoptosis, the number of CC3
 +
 cells in a whole gonadal section from each of 
several embryos of each genotype was manually counted and the area of each section 
measured with ImageJ. For quantifying cell proliferation and SRY-expressing cells, the 
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number of Ki67
+
 or SRY
+
 cells in three randomly chosen areas of arbitrary and identical size 
was manually counted in a whole gonadal section from each of several embryos of each 
genotype.  
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Results 
 
SoxC genes are predominantly expressed in the fetal gonadal somatic cell lineages 
 
Sox4 has previously been shown to be strongly expressed in adult mouse ovaries and testes 
(van de Wetering et al., 1993). However, detailed information about its expression pattern 
during mouse gonadogenesis is lacking. We therefore analysed the expression of Sox4, Sox11 
and Sox12 in the developing fetal gonads from 10.5 to 14.5 dpc. qRT-PCR analysis (Fig. 1A) 
showed that all three genes were expressed in CD1 mouse fetal gonads, with similar levels in 
XX and XY gonads during this period. Expression of all three genes gradually decreased 
during the time course, with Sox4 expression appearing to plateau after 12.5 dpc.  
 
We further analysed the spatial expression pattern of SoxC genes using in situ hybridisation 
on sagittal sections of 13.5 dpc CD1 mouse embryos (Fig. 1B). In the fetal ovary, Sox4 was 
strongly expressed in the domain close to mesonephros (future ovarian medulla), while Sox11 
and Sox12 were expressed throughout the tissue. In the fetal testis, intensive staining of Sox4 
mRNA was observed within testis cords comprising cluster of germ cells and surrounding 
Sertoli cells. Sox12 expression was detected both within testis cords and in the interstitium. In 
contrast, staining of Sox11 transcripts appeared to be restricted to the interstitium. In 
accordance with these observations, elevated levels of SoxC genes were detected by qRT-
PCR in W
 e
 fetal gonads which lack germ cells, possessing an increased proportion of somatic 
cells (Buehr et al., 1993), compared with wild type gonads  (Fig. 1C). These results indicate 
that SoxC genes are predominantly expressed in the somatic compartment of fetal gonads. 
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To further delineate the cell lineages expressing SoxC genes, we analysed their expression in 
13.5 dpc fetal gonads from the Wt1-RG (red-green) mouse strain carrying an mCherry-EGFP 
transgene under the control of Wt1 regulatory sequence (Zhao et al., 2014b). Gonadal cells 
from Wt1-RG fetal ovaries were sorted into RG
 +
 (mCherry
 +
 EGFP
 +
) and RG
 –
 (mCherry
 –
 
EGFP
 –
) cell populations, whereas cells from Wt1-RG testes were sorted into three distinct 
populations based on their fluorescence intensities: RG
 Hi
, RG
 Lo 
and RG
 –
 (Supplemental Fig. 
S1). qRT-PCR analyses of lineage marker genes indicate that XX RG
 +
 and RG
 –
 cell 
populations were enriched for granulosa and germ cells respectively, whereas XY RG
 Hi
, RG
 
Lo
, and RG
 –
 populations were enriched for Sertoli, interstitial (including fetal Leydig cells) 
and germ cells respectively (Supplemental Fig. S1).  
 
SoxC genes were expressed at high levels in the somatic cell compartment (RG
 +
 population 
in fetal ovaries; and RG
 Hi
 and RG
 Lo
 populations in fetal testes) with much lower levels in 
RG
 –
 germ cells (Fig. 1D), in agreement with our in situ hybridisation and W
 e
 qRT-PCR 
results. In 13.5 dpc fetal testes where Sertoli and fetal Leydig cells have developed by this 
stage, SoxC genes showed clearly diverged expression patterns (Fig. 1D): Sox4 was 
expressed at high levels in RG
 Hi
 Sertoli cells and slightly lower levels in RG
 Lo
 interstitial 
cells; Sox12 was expressed at roughly equal levels in RG
 Hi
 Sertoli cells and RG
 Lo
 interstitial 
cells. In contrast, Sox11 was predominantly expressed in RG
 Lo
 interstitial cells with 
substantially lower levels in RG
 Hi
 Sertoli cells.  
 
Common somatic progenitor cells are believed to give rise to sex-specific somatic cell 
lineages (granulosa or Sertoli; stromal or interstitial) in the fetal testis and ovary (Albrecht 
and Eicher, 2001; Burgoyne et al., 1988; Palmer and Burgoyne, 1991a, b). It is thus highly 
likely that the expression of SoxC genes in ovarian somatic cell lineages (granulosa and 
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stromal) follows the same patterns in their corresponding testicular lineages. This 
extrapolation is supported by a previously published mouse fetal gonadal expression dataset 
conducted on sorted cell lineages (Supplemental Fig. S2; Jameson et al., 2012).  
 
SOX4 influences the organ shape of fetal gonads in mice 
 
Based on the identified expression patterns of SoxC genes in mouse fetal gonads, we next 
focused our study on Sox4, as it is highly expressed in the supporting cell lineage that 
orchestrates fetal gonad development. While Sox12 is also expressed in the supporting cells, 
it is the weakest transactivator amongst the SOXC factors (Dy et al., 2008), and has been 
shown previously to be dispensable for mouse embryonic development and fertility in adult 
mice (Hoser et al., 2008).  
 
The gross morphology of both XX and XY Sox4
 –/–
 fetal gonads at 13.5 dpc largely 
resembled that of wild type (Fig. 2A): testis cords formed in Sox4
 –/–
 testes, while no overt 
morphological changes were noticed in Sox4
 –/–
 ovaries. Mutant embryos were 
indistinguishable from their littermates macroscopically (Supplemental Fig. S3A). However, 
Sox4
 –/–
 fetal gonads were significantly longer and thinner than wild type in both sexes (Fig. 
2A,C,D): on average, Sox4
 –/–
 ovaries were ~27% longer and ~20% thinner than wild type, 
and Sox4
 –/–
 testes ~24% longer and ~9% thinner. The effect of SOX4 appears to be specific 
to fetal gonads, as neither the length of embryo trunk axis (Supplemental Fig. S3B) nor the 
shape of the fetal kidney, another organ originating from the urogenital ridge (Fig. 2B,E,F), 
were altered in Sox4
 –/–
 embryos. 
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Anti-laminin immunofluorescence revealed significantly more external testis cords (those 
running immediately beneath the coelomic epithelium; Combes et al., 2009) in Sox4
 –/–
 testis 
than wild type at 14.5 dpc (Fig. 3), consistent with a previously reported correlation between 
the gonad length and the number of testis cords (Nel-Themaat et al., 2009; Wainwright et al., 
2014). Since the number of external testis cords decreases from 12.5 to 14.5 dpc in wild type 
testes due to extensive cord remodelling (Combes et al., 2009; Nel-Themaat et al., 2009), the 
observed increase in testis cord number in Sox4
 –/–
 testis could be caused by either excess 
formation of new cords or stabilisation of existing ones. Future experiments examining the 
dynamics of cord formation and remodelling in Sox4
 –/–
 fetal testes across 12.5 to 14.5 dpc 
should help to clarify this issue.  
 
SOX4 is likely to modulate gonad shape through mechanisms common to both testes and 
ovaries, as Sox4
 –/–
 testes and ovaries underwent similar shape changes. We therefore reason 
that the increase in cord number was unlikely to drive the elongation of the gonad domain in 
Sox4
 –/–
 fetal testes, since cord-like structures were absent in Sox4
 –/–
 fetal ovaries. Instead, we 
suggest that the increased number of testis cords in Sox4
 –/–
 fetal testis may be a result of the 
extended gonad domain available for cord formation, in agreement with a previously 
proposed model that the number of testis cords may be determined by the space available in 
the gonadal field (Wainwright et al., 2014).  
 
We have recently reported that one cause of increased gonad length is a defect in Ift144, a 
gene encoding a component of the primary cilium (Wainwright et al., 2014). We therefore 
analysed the presence of primary cilia in Sox4
 –/–
 fetal gonads using immunofluorescence. No 
apparent difference in primary cilia distribution between Sox4
 –/–
 and wild type fetal gonads 
was observed (Supplemental Fig. S4). Although we cannot rule out that Sox4 regulates 
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primary cilium-mediated signalling to affect gonad length without affecting the formation 
and distribution of primary cilia, our results do not support an active involvement of primary 
cilia signalling in this phenotype.  
 
We next analysed cell apoptosis and proliferation, since SoxC genes have been shown to be 
essential for the survival of mesenchymal and neural progenitor cells (Bhattaram et al., 
2010). Immunostaining for the apoptosis marker cleaved Caspase-3 and the mitosis marker 
Ki-67 showed no significant changes in cell survival or proliferation in Sox4
 –/–
 gonads 
compared with wild type (Supplemental Figs. S5-S6), suggesting that SOX4 influences the 
shape of fetal gonads via other cellular and molecular mechanisms. 
  
SOXC factors have been shown to directly regulate Tead2 (Bhattaram et al., 2010; Poncy et 
al., 2015), a co-activator of the Hippo pathway, which plays a critical role in controlling 
organ shape and size in development and cancer (Zhao et al., 2011). We found that Tead2 
was significantly downregulated in XY but not XX mutant gonads at 13.5 dpc (Fig. 2G). 
Similar to previous studies (Bhattaram et al., 2010; Poncy et al., 2015), no significant 
changes in expression of other Hippo pathway genes, including Amotl2, Ctgf and Cyr61, 
were observed in Sox4
 –/–
 fetal gonads (Fig. 2H-J).  
 
Sox4 loss-of-function does not perturb the specification of somatic cell lineages in mouse 
fetal gonads  
 
Sox4 has been shown to control cell fate determination in neural progenitor cells (Bergsland 
et al., 2006) and skeletogenesis (Bhattaram et al., 2014). We therefore sought to determine 
whether specification of major somatic cell lineages was affected in the developing Sox4
 –/–
 
  16 
fetal gonads. Histological examination of gonad sections at 14.5 dpc showed no apparent 
difference between the mutant and wild type gonads (Fig. 4A). Immunofluorescence analysis 
of several markers of the major gonadal cell lineages, including AMH (a marker of Sertoli 
cells), HSD3 (a steroidogenic enzyme expressed by fetal Leydig cells), and FOXL2 (a 
marker of granulosa cells) showed overall similar expression patterns in Sox4
 –/–
 and wild 
type gonads (Fig. 4B): AMH-expressing Sertoli cells and HSD3-expressing fetal Leydig 
cells were present in Sox4
 –/–
 fetal testes and were absent in Sox4
 –/–
 ovaries. Conversely, 
FOXL2-positive granulosa cells were only detected in Sox4
 –/–
 ovaries but not in Sox4
 –/–
 
testes. Quantitative analysis of these marker genes at 13.5 dpc using qRT-PCR confirmed 
similar expression levels of these marker genes in Sox4
 –/–
 and wild type gonads 
(Supplemental Fig. S7A–C). 
 
We further analysed additional marker genes of the gonadal somatic cell lineages at 13.5 dpc 
using qRT-PCR. In line with our immunofluorescence analysis showing the presence of the 
major somatic cell lineages in Sox4
 –/–
 gonads, Sf1 (also known as Nr5a1), a gene required for 
the differentiation of somatic cell lineage in both sexes (Luo et al., 1994), showed no 
significant expression changes between Sox4
 –/–
 and wild type gonads (Fig. 4C). Testicular 
cell lineage markers, including Dhh (Sertoli), Cyp11a1 and Star (fetal Leydig), showed 
similar expression levels in Sox4
 –/–
 and wild type testes (Fig. 4D–F). Similarly, expression of 
Fst, a marker of granulosa cells and a downstream target of FOXL2 (Blount et al., 2009; 
Kashimada et al., 2011), remained unaltered in Sox4
 –/–
 ovaries compared with wild type (Fig. 
4H). Interestingly, we found that Wnt4, a key driver of fetal ovarian development (Vainio et 
al., 1999), was slightly up-regulated in Sox4
 –/–
 fetal ovaries compared with wild type ovaries 
(Fig. 4G), suggesting that SOX4 may directly or indirectly repress Wnt4 transcription in fetal 
ovaries. 
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Together, these data do not support an active role of Sox4 in cell fate determination of fetal 
gonadal somatic cell lineages, in accordance with previous findings that various marker genes 
of embryo patterning and cell lineage specification are expressed normally in SoxC mutant 
embryos (Bhattaram et al., 2010). 
  
SOX4 negatively regulates Sry and Sox9 in mouse fetal testes  
 
Complex interplay among different SOX proteins has been well documented (Kamachi and 
Kondoh, 2013; Wegner, 2010). For instance, SOX4 and SOX9 cooperate to control bile duct 
development (Poncy et al., 2015), whereas SOXC proteins antagonise SOX9 activity in 
skeletogenesis (Bhattaram et al., 2014). Therefore, to identify potential regulatory 
interactions of SOX proteins, we analysed Sox4
 –/–
 fetal gonads for the expression of multiple 
Sox genes, including SoxC (Sox4/11/12), Sry and SoxE (Sox8/9/10) genes. 
 
Levels of Sox4 transcripts were substantially decreased but detectable using qRT-PCR at 13.5 
dpc in Sox4
 –/–
 fetal gonads (~35% of that in wild type; Supplemental Fig. S7E), suggesting 
that the transcription termination conferred by the single polyadenylation signal inserted 
upstream of the Sox4 coding region in this allele (Schilham et al., 1996) may not be complete. 
Expression of Sox11 and Sox12 remained largely unchanged in Sox4
 –/–
 fetal gonads 
compared with wild type, with the exception that Sox11 was slightly up-regulated in Sox4
 –/–
 
ovaries (Supplemental Fig. S7F,G), suggesting Sox4 may cross regulate Sox11 transcription 
in fetal ovaries. 
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In mice, Sry is expressed in XY genital ridges within a very short time window from 10.5 to 
12.5 dpc, with its expression almost completely extinguished by 13.5 dpc (Bullejos and 
Koopman, 2001; Hacker et al., 1995; Jeske et al., 1995; Koopman et al., 1990; Wilhelm et al., 
2005). We observed no obvious changes in SRY protein expression or the number of SRY-
expressing cells in XY Sox4
 –/–
 genital
 
ridges at 11.5 dpc compared with wild type 
(Supplemental Fig. S8), indicating that SOX4 may not contribute to the induction of Sry 
expression in fetal testes. Interestingly however, we found that Sry transcripts were clearly 
detectable in Sox4
 –/–
 fetal testes at 13.5 dpc (~6 fold higher than the background level in wild 
type testes; Fig. 5A), albeit at much lower levels than its peak expression at 11.5 dpc (~8% of 
peak levels, data not shown). This result raises the possibility that Sox4 may contribute to 
down-regulating Sry in the mouse fetal testis.  
 
Of the three SOXE group members, SOX9 and SOX8, cooperate to maintain the male sexual 
fate at both the fetal (Barrionuevo et al., 2009; Georg et al., 2012) and adult stages 
(Barrionuevo et al., 2016). The other SoxE gene, Sox10, is also expressed in Sertoli cells and 
has been shown to be able to sex reverse XX mice when overexpressed (Polanco et al., 2010). 
We found that the expression of Sox8 and Sox10 remained unchanged in Sox4
 –/–
 fetal testes 
at 13.5 dpc (Supplemental Fig. S7H,I). In contrast, Sox9 mRNA levels were increased by 
~50% in the mutant testes compared with wild type (Fig. 5B), indicating that SOX4 may 
selectively repress the expression of Sox9 but not Sox8 or Sox10.  
 
Given the critical involvement of the Sox9-TESCO enhancer in the initiation and 
maintenance of Sox9 expression in the fetal testis (Sekido and Lovell-Badge, 2008), we next 
examined whether SOXC factors regulate TESCO activity, using a well-established in vitro 
reporter assay system (Polanco et al., 2010; Sekido and Lovell-Badge, 2008; Uhlenhaut et al., 
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2009; Zhao et al., 2014a). We found that SOX4 potently repressed the activation of TESCO 
by SF1, SRY + SF1, or SOX9 + SF1 (~90% repression in each situation; Fig. 5C), despite a 
~3-fold activation of TESCO on its own (Supplemental Fig. S9). SOX11 and SOX12 
manifested weaker repressor activities compared with SOX4 (~70% or ~50% repression 
respectively; Fig. 5C) in the presence of SF1 and/or SRY/SOX9 (Fig. 5C). However, SOX11 
or -12 alone activated TESCO more strongly than SOX4 (Supplemental Fig. S9). Together, 
these results reveal a context-dependent role for SOXC proteins in negatively regulating Sox9 
expression via repressing the TESCO enhancer in mouse fetal testes. 
 
SOX4 promotes spermatogenic differentiation of male fetal germ cells  
 
Fetal germ cells adopt either male or female sexual fate depending on the molecular cues 
provided by their surrounding somatic cells (Bowles and Koopman, 2013; Spiller and 
Bowles, 2015). In the fetal ovary they switch on Stra8 and enter meiosis in response to 
retinoic acid, but in contrast, in the fetal testis germ cells are mitotically arrested and up-
regulate male fate markers including Nanos2, Dnmt3l and p15
 INK4b
 (Cdkn2b).  
 
We sought to determine whether the disruption of Sox4 might affect fetal germ cell 
development. qRT-PCR analysis showed that upregulation of Stra8 at 13.5 dpc was similar in 
Sox4
 –/–
 and wild type fetal ovaries (Fig. 6F), indicating that the initiation of meiosis of 
female germ cells had proceeded normally in Sox4
 –/–
 ovaries. Immunofluorescence for 
SYCP3, a marker of meiosis, revealed comparable expression patterns at 14.5 dpc in wild 
type and Sox4
 –/–
 ovaries (Fig. 6G), confirming the entry of meiosis of fetal germ cells was 
unperturbed in the mutant ovaries.  
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Consistent with the unperturbed differentiation of Sertoli and fetal Leydig cells in Sox4
 –/–
 
fetal testes (Fig. 4B), germ cells in these mutant testes adopted male fate, and did not up-
regulate meiosis markers Stra8 and SYCP3 (Fig. 6F and data not shown). Instead, expression 
of Nanos2 and Dnmt3l, markers of spermatogenic differentiation, were detected in the mutant 
testes at 13.5 dpc (Fig. 6A,B), confirming that germ cells in Sox4
 –/–
 fetal testes had embarked 
on spermatogenesis. However, both Nanos2 and Dnmt3l were expressed at levels 
substantially lower than those in wild type testes (Fig. 6A,B), indicating that the 
differentiation of male germ cells was severely impaired in Sox4
 –/–
 testes.  
 
As male germ cell fate commitment hinges on a fine balance between maintaining 
pluripotency and initiating spermatogenic differentiation, we analysed the expression of 
several genes that play key roles in maintaining the pluripotency of male germ cells, 
including Nodal, Cripto, Nanog, Sox2 and Oct3/4 (Spiller et al., 2012; Western et al., 2010). 
Our data revealed that the levels of Cripto, and its downstream target Nanog (Miles et al., 
2013) were doubled at 13.5 dpc in Sox4
 –/–
 testes compared with wild type (Fig. 6D,E). 
Expression levels of Nodal, Sox2, and Oct3/4 remained unchanged (Supplemental Fig. S7J-
L). No significant change in Fgf9, encoding a Sertoli cell-secreted factor pivotal in promoting 
male germ cell fate (Barrios et al., 2010; Bowles et al., 2010), was found (Supplemental Fig. 
S7D). 
 
Another male germ cell fate marker, p15
INK4b
, is up-regulated in male germ cells at 14.5 dpc 
and considered to contribute to the mitotic arrest of male germ cells (Spiller et al., 2012; 
Western et al., 2008). Interestingly, p15
INK4b
 was upregulated precociously in Sox4
 –/–
 testes at 
13.5 dpc (Fig. 6C), suggesting that male differentiation and mitotic arrest of germ cells may 
be uncoupled. 
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In summary, these data indicate that although SOX4 does not seem to affect the cell fate 
commitment of fetal germ cells, it plays an important role in promoting the spermatogenic 
differentiation of male germ cells.  
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Discussion 
 
SOX transcription factors play crucial roles in a wide variety of developmental contexts 
(Kamachi and Kondoh, 2013). In the developing mouse gonads, two SOX transcription 
factors, SRY and SOX9, play instructive roles in male sex determination and fetal testis 
development (Koopman et al., 1991; Vidal et al., 2001). We show in the current study that 
another SOX protein, SOX4, also plays important roles in mouse fetal gonad development by 
modulating morphogenesis of the developing gonads and promoting male germ cell 
differentiation. 
 
SOX4 modulates morphogenesis of both fetal testes and ovaries 
 
Organ shape and size are determined through tightly regulated and highly stereotypic 
processes. While some progress has been made in unravelling developmental pathways 
regulating organ and embryo size, little is understood regarding how organ shape is regulated. 
Our morphometric analysis of fetal gonads reveals that both Sox4
 –/–
 testes and ovaries were 
longer and thinner compared with wild type at 13.5 dpc. Since mouse fetal gonads become 
plumper and shorter from 11.5 to 13.5 dpc (Nel-Themaat et al., 2009), one explanation is that 
Sox4 inactivation may have simply caused a delay in gonad development, either cell-
autonomously or secondarily to developmental defects in other organs, such as the heart. 
However, a number of somatic marker genes, including Star, Cyp11a1, and Hsd3b, that are 
dynamically expressed during this period (Büdefeld et al., 2009; Yao et al., 2002), showed 
similar expression levels in Sox4
 –/–
 and wild type gonads at 13.5 dpc, arguing against a 
developmental delay. 
 
  23 
We suggest that SOX4 is part of the mechanism by the shape of fetal gonads is determined. 
Supporting this hypothesis, SoxC genes have been shown to be essential for organogenesis in 
mouse embryos by ensuring the survival of neural and mesenchymal progenitor cells 
(Bhattaram et al., 2010). Tead2, a direct target of SOXC proteins and a Hippo/YAP pathway 
component, has been suggested to mediate the pro-survival activity of SOXC proteins 
(Bhattaram et al., 2010). We found that Tead2 was down-regulated only in Sox4
 –/–
 fetal 
testes but not ovaries, suggesting that Tead2 may not be the main target required for 
mediating SOX4’s activity. Alternatively, SOX4 may regulate different targets in testes 
(namely Tead2) and ovaries (other unidentified targets) to achieve similar outcomes.  
 
Consistent with our observation that neither cell survival nor proliferation was significantly 
altered in Sox4
 –/–
 fetal gonads, estimates based on gonad length and width suggested that the 
gonad volume was not altered substantially in Sox4
 –/–
 embryos, despite significant changes 
observed in external profile. We therefore speculate that SOX4 modulates the gonad shape by 
regulating genes involved in extracellular matrix remodelling, cell-cell interaction and cell 
migration. Supporting this concept, genes encoding cell adhesion molecule E-Cadherin and 
metalloprotease ADAM19 have been identified as SOXC direct targets in heart outflow tract 
remodelling (Paul et al., 2014).  
 
Mouse ovaries and testes undergo gradual changes in shape during fetal development and 
become oval-shaped before they descend to their final location in later embryonic life, 
namely the lower abdomen for ovaries and the scrotum for testes. It is conceivable that the 
changes in shape of gonads may facilitate their translocation across the abdominal cavity (and 
the abdominal wall in the case of testis descent). However, the embryonic lethality of Sox4
 –/–
 
embryos at 14.5 dpc precludes us from testing this hypothesis. Conditional Sox4 knockout 
  24 
mouse models should help to evaluate this hypothesis by allowing the examination of the 
shape and position of gonads at later developmental stages. 
 
Sox4 regulates male fetal germ cell development 
 
Our data indicate that Sox4 is required for proper progression of male germ cell 
differentiation but appears dispensable for female germ cell development. We found that 
disruption of Sox4 in fetal testes leads to up-regulation of genes involved in maintaining 
pluripotency, including Cripto and its downstream target Nanog, and down-regulation of 
spermatogenic differentiation markers Nanos2 and Dnmt3l. These results suggest SOX4 
plays an important role in restricting the period of pluripotency in male germ cells by 
repressing the Cripto/Nodal pathway. Reduced activities of Cripto and its target Nanog 
should allow male germ cells to proceed with spermatogenic differentiation (Spiller et al., 
2012).  
 
How does SOX4 regulate male germ cell development? We found that Sox4 is expressed 
highly in Sertoli and interstitial cells, and at a much lower level in germ cells. It is possible 
that SOX4 in Sertoli/interstitial cells regulates the secretion of certain signalling molecules to 
regulate Cripto expression in germ cells. Such an example has recently been described. 
Emx2, a gene expressed in Sertoli cells, regulates Fgf9, a Sertoli cell-secreted molecule 
crucial in inducing both the pluripotency genes and male differentiation markers (Barrios et 
al., 2010; Bowles et al., 2010; Spiller et al., 2012), to modulate male germ cell development 
(Tian-Zhong et al., 2016). However, Fgf9 does not seem to be a SOX4 target, as its 
expression appeared unchanged in Sox4
 –/–
 fetal testes. It is possible that SOX4 may regulate 
unidentified signalling molecules in Sertoli/interstitial cells to fulfil this role. Alternatively, 
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SOX4 in germ cells, albeit at very low levels, may cell-autonomously restrict Cripto 
expression. Further studies involving Sertoli and germ cell-specific conditional Sox4 
knockout models are required to elucidate the molecular mechanisms underlying its ability to 
regulate Cripto and male germ cell differentiation. 
 
SOXC proteins as context-dependent transcriptional repressors  
 
Our results uncover a hitherto unappreciated role of SOXC proteins in transcriptional 
repression of Sox9, adding an extra level of control of Sox9 expression in fetal gonad 
development. The negative regulation of Sox9 by SOX4, and possibly SOX11 and -12, in 
fetal Sertoli cells may contribute to the homeostasis of Sox9. Since SoxC genes are highly 
expressed in female somatic cells, SOXC proteins may also contribute to repression of Sox9 
in fetal ovaries. However, no apparent up-regulation of Sox9 was observed in Sox4
 –/–
 fetal 
ovaries. Two possibilities may account for this. First, other mechanisms to repress Sox9 
expression involving the RSPO1/WNT4/ß-Catenin or FOXL2 are in place in the fetal ovary 
(Greenfield, 2015). Second, SOX11/12 may function redundantly in this context to repress 
Sox9, as has been described in other developing tissues (Bhattaram et al., 2010). 
 
SOXC proteins possess a single transactivation domain at the carboxyl-terminus and 
predominantly function as transcriptional activators (Wegner, 2010). Our in vitro reporter 
assays show that SOXC proteins induce TESCO activity on their own but potently repress the 
activation of TESCO-mediated transcription in the presence of SF1 (either SF1 alone or 
combined SF1 and SRY/SOX9), indicating SOXC proteins may function as transcriptional 
repressors in a context-dependent manner. It is unclear how SOXC proteins exert repressor 
activity in the absence of a transcriptional repressor domain. SOXC factors may directly 
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interact with SF1 and repress its ability to activate TESCO-mediated transcription. It is also 
possible that the formation and stabilisation of a repressor complex containing SOXC 
proteins and partner co-repressors (Koumangoye et al., 2015) may be facilitated by SF1. 
Alternatively, the binding of SOXC proteins to SOX binding motifs within TESCO may 
sterically hinder the binding of SF1 to its nearby binding sites. In the presence of SRY or 
SOX9, SOXC proteins may also compete with SRY/SOX9 for DNA binding.  
 
We found that the down-regulation of Sry was delayed in Sox4
 –/–
 fetal testes. In mice, Sry 
expression is switched off only 2 days after reaching its peak (Kashimada and Koopman, 
2010). The molecular mechanisms underlying the down-regulation of Sry are not fully 
understood (Larney et al., 2014). SOX9 appears to be involved, as prolonged Sry expression 
has been observed in conditional Sox9 knockout gonads (Barrionuevo et al., 2006; 
Chaboissier et al., 2004). However, down-regulation of Sry also occurs in the ovarian portion 
of ovotestes where Sox9 is not expressed, suggesting that additional unidentified factors may 
also contribute to down-regulating Sry (Wilhelm et al., 2009). We suggest that SOX4 may be 
a contributing factor, possibly via the repressor function revealed in this study. 
  
Among SOXC proteins, SOX11 is the strongest transactivator with its transactivating 
capacity several times more potent than that of SOX4 (Dy et al., 2008and the present study). 
However, the transactivating capacity of SOXC proteins does not necessarily correlate with 
the severity of certain organ defects in mice deficient for SoxC genes. For example, the 
defects in heart outflow tract are more severe in Sox4
 –/–
 mice than those in Sox11
 –/–
 or Sox4
 
+/–
 Sox11
 +/–
 mice (Bhattaram et al., 2010; Schilham et al., 1996; Sock et al., 2004). It is thus 
puzzling why Sox4 deficiency causes the most severe phenotype if transactivation is the main 
function of SOXC proteins in vivo. It has been postulated that SOX4 may be present and 
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function in non-cardiac neural crest, non-mesodermal cells (that do not express Sox11), e.g. 
pharyngeal endoderm cells, during outflow tract development but direct evidence is lacking 
(Paul et al., 2014).  
 
Our results from TESCO-luciferase reporter assays show that SOX4 is the most potent 
transcriptional repressor among SOXC factors, followed by SOX11 and SOX12. 
Interestingly, this order mimics the order of phenotypic severity of heart outflow tract 
malformation in SoxC knockout mouse models, raising the possibility that SOXC proteins 
may function as transcriptional repressors in other developmental contexts in vivo, and their 
repressor activities may contribute to the different phenotypic outcomes in knockout mouse 
models. Supporting this hypothesis, knockout of Sox4 in primary mouse limb bud cells 
resulted in upregulation of a number of genes (Bhattaram et al., 2010); similarly, 
overexpression or knockdown of Sox4 in various cancer cell lines caused down- or up-
regulation of many downstream genes respectively (Vervoort et al., 2013). We suggest that 
mouse models carrying mutated SoxC alleles with the native transactivation domain replaced 
by an ectopic transactivation or repressor domain such as the VP16 or engrailed repressor 
domain (Bergsland et al., 2006; Zhao et al., 2014a), should help to solve this puzzle.  
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Figure legends 
 
Fig. 1. Sox4, Sox11 and Sox12 are expressed in the developing mouse fetal gonads. (A) 
qRT-PCR analyses of SoxC genes in CD1 mouse fetal gonads from 10.5 to 14.5 dpc. Mean ± 
s.e.m; n = 3. (B) In situ hybridisation of sagittal sections of XX or XY CD1 embryos at 13.5 
dpc. Dashed lines delineate testis cords. Scale bar, 100 μm. (C) qRT-PCR analyses of SoxC 
genes on wild type (WT) or W
 e
 fetal gonads at 14.5 dpc. Mean ± s.e.m; n = 4. (C) qRT-PCR 
analyses of SoxC genes on sorted somatic and germ cell populations from Wt1-RG fetal 
gonads. Cells from multiple pairs of fetal gonads were pooled and sorted for mCherry and 
EGFP (see also Supplemental Fig. S1). Mean ± s.e.m of triplicate qPCR reactions. 
 
Fig. 2. Sox4 affects the morphology of mouse fetal gonads. (A,B) Bright-field images of 
13.5 dpc gonads (A) or kidneys (B) from wild type (WT) or Sox4
 –/–
 embryos. Representative 
images from littermate WT and Sox4
 –/–
 embryos were shown. Scale bars, 0.5 mm. (C-F) 
Quantitation of the length or width of fetal gonads (C,D) or kidneys (E,F). Mean ± s.d.; n = 9, 
11, 6 or 7 (XY WT, XX WT, XY Sox4
 –/–
or XX Sox4
 –/–
). *P<0.05, **P<0.01, multiple t tests. 
(G-J) qRT-PCR analyses of Hippo pathway genes on 13.5 dpc fetal gonads. Tead2, a known 
Sox4 target gene, was significantly down-regulated in Sox4
 –/–
 testes compared with wild type 
(WT) controls. Mean ± s.e.m; n = 5. *P<0.05 (multiple t tests); ns, not significant. 
 
Fig. 3. Sox4
 –/–
 fetal testes develop significantly more testis cords. The largest sagittal 
sections of 14.5 dpc wild type (WT) or Sox4
 –/–
 testes were stained with an anti-laminin 
antibody to reveal testis cords. (A) Representative images from littermate wild type (WT) and 
Sox4
 –/–
 embryos were shown. Scale bar, 100 μm. (B) Quantitation of testis cords. Mean ± 
s.d.; n = 6 (WT) or 5 (Sox4
 –/–
). **P<0.01, Mann-Whitney test. 
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Fig. 4. The differentiation of gonadal somatic cell lineages appeared unperturbed in 
Sox4
 –/–
 fetal gonads. (A) Histological analysis of gonadal sections at 14.5 dpc using 
Hematoxylin and Eosin staining. (B) Immunofluorescence analyses of 14.5 dpc gonadal 
sections. Sertoli cells (marked by AMH, green) and fetal Leydig cells (marked by HSD3, 
magenta) were present in XY Sox4
 –/–
 testes, while granulosa cells (marked by FOXL2, 
magenta, bottom panel) were present in XX Sox4
 –/–
 ovaries. Nuclei were counterstained with 
DAPI (blue). Dashed lines delineate gonad perimeters. Scale bars (A,B), 50 μm. (C-H) qRT-
PCR analyses of additional somatic cell lineage markers at 13.5 dpc. Expression of testicular 
somatic cell markers (C-F) and an ovarian marker Fst (H) remained unchanged in Sox4
 –/–
 
gonads compared with wild type (WT). Another ovarian marker Wnt4 (G) was slightly up-
regulated in Sox4
 –/–
 ovaries. Mean ± s.e.m; n = 5. *P<0.05 (multiple t tests); ns, not 
significant. 
 
Fig. 5. SOX4 negatively regulates Sry and Sox9 in mouse fetal gonads. (A,B) qRT-PCR 
analyses on 13.5 dpc gonads revealed significantly higher levels of Sry (A) and Sox9 (B) in 
Sox4
 –/–
 testes compared to wild type. Mean ± s.e.m; n = 5. **P<0.01, ***P<0.001, multiple t 
tests. (C) SOXC proteins strongly repressed the activation of TESCO by SF1, SRY and 
SOX9. Reporter assays were performed in HEK293 cells. The activity of TESCO-Luc co-
transfected with the empty vector in the absence of SF1 was set to 1. For simplicity, only the 
+SF1 data are presented here, as mean ± s.e.m (n = 3). **P<0.01, one-way repeated measures 
ANOVA with Holm-Sidak multiple comparisons test. 
 
Fig. 6. Sox4 regulates differentiation of male fetal germ cells. (A-F) qRT-PCR analyses of 
markers of germ cell development on 13.5 dpc gonads. Mean ± s.e.m; n = 5. *P<0.05, 
**P<0.01, ***P<0.001 (one-way ANOVA with Sidak multiple comparisons test); ns, not 
significant. (G)  Immunofluorescence showing germ cells (marked by DDX4, magenta) in 
  40 
both wild type and Sox4
 –/–
 ovaries expressed SYCP3 (green), a meiotic marker. Nuclei were 
counterstained with DAPI (blue). Scale bar, 50 μm. 
 
Highlights 
 
 SoxC genes are expressed in mouse fetal gonads, predominantly in somatic cells. 
 SOX4 activity influences organ shape in developing ovaries and testes. 
 SOX4 activity also promotes the differentiation of male germ cells. 
 SOX4 both activates and represses transcription depending on context. 
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